Skip to main content

Scientists Are Using The Measles Vaccine to Develop a 'Trojan Horse' Against COVID-19


.
Mere months into the pandemic, some 115 coronavirus vaccines have been put into development worldwide. France's Pasteur Institute is working on using a modified measles vaccine to "trick" the body into producing antibodies against the novel coronavirus.
In March, Norway's Coalition for Epidemic Preparedness Innovations approved an initial grant of US$4.9 million to fund the institute's preclinical research. It's one of eight vaccine candidates CEPI is backing, though only two or three projects will be funded all the way through to the regulation and approval stage.
CEPI estimates it will cost US$2 billion to develop a COVID-19 vaccine that can be produced in sufficient quantities to immunize billions in record time. But virologist Frédéric Tangy, head of the institute's vaccine innovation lab, says immunization is the only real solution to the pandemic.
He compares measures like social-distancing and self-isolation to putting a Band-Aid on a gaping wound.
"According to what we know about the contagious potentials of SARS-CoV-2, 60 percent to 70 percent of the human population needs to be immunized," Tangy told Business Insider, using the scientific name for the virus.

 Pasteur Institute has an enviable track record in fighting infectious diseases

Named after Louis Pasteur, the pioneering French biochemist who developed the anthrax and rabies vaccines, the Pasteur Institute opened in 1888. In the intervening years, it's made game-changing advances against typhoid fever, tuberculosis, polio, yellow fever, HIV, and other conditions.
Currently, Tangy said, nearly all 133 departments on the institute's Paris campus are focused on the COVID-19 pandemic.
In January, Pasteur scientists completed the first full genome sequencing of the coronavirus in Europe, just days after France's first COVID-19 cases were reported. It was an essential step in understanding if the virus had significantly mutated from its initial discovery in Wuhan, China.
Thankfully that doesn't seem to have been the case.
The institute has tested a modified measles vaccine to fight other viruses

Tangy's team is modifying a standard measles vaccine to include a single SARS-CoV-2 protein. They're hoping it will trigger an immune response equivalent to the current MMR vaccine that protects against measles, mumps, and rubella.
Live attenuated vaccines induce a strong and long-lasting immunity after a single injection and are inexpensive to manufacture. Using a licensed measles vaccine also means the testing and patenting processes will go faster.
"Every factory in the world can produce a vaccine for measles," Tangy said.
The strategy has already yielded promising results for the institute's prototype vaccine for Chikungunya, which infects millions in South Asia and Africa every year, causing joint swelling, muscle pain, and rashes. It can prove fatal in the very young and old, and in people with underlying health issues.
After seven years of clinical trials, the Chikungunya vaccine is finally in Phase 3, when its efficacy is being tested in thousands of people.
"And we consider that fast," Tangy said. The institute's coronavirus vaccine candidate is moving at breakneck speed by comparison.

Comments

Post a Comment

Popular posts from this blog

Scientists Discover Deep-Sea Bacteria Have a Metabolism Unlike Anything We've Seen Before

A curious kind of bacteria found on the floor of the deep ocean might have a metabolism unlike anything we've seen before. Known as Acetobacterium woodii, scientists in Germany claim that this species, which also lives in the intestines of termites, can both create and use hydrogen and carbon dioxide to produce energy all on its own, even without the need for oxygen.  The ability to survive on organic and inorganic substances alike without oxygen makes this bacterium quite unique among microorganisms, and while scientists have long suspected something like this existed, it's never been clearly described among acetogenic bacteria, which produce methane free from oxygen.  "There have already been speculations that many ancient life forms possess the kind of metabolism that we have described in A. woodii," microbiologist Volker Müller from Goethe University Frankfurt explains. "This is assumed, for example, for the Asgard archaea that were just discovered a few year...
Post a Comment
Read more

Loss of Smell Should Be Listed as an Early COVID-19 Symptom, Study Finds

According to a new study in the United States, sudden loss of smell really does appear to be an early sign of COVID-19, especially in those with mild cases. In over a thousand patients with undiagnosed flu-like symptoms, experts found those with a loss of smell and taste had a 10-fold greater chance of testing positive for COVID-19. "The most common first sign of a COVID-19 infection remains fever, but fatigue and loss of smell and taste follow as other very common initial symptoms," clarifies otolaryngologist and head and neck surgeon Carol Yan from the University of California San Diego. The good news? If you're sniffing isn't up to snuff, it won't be forever, and it might actually bode well for your recovery. Surveying 1,480 patients, researchers found just over 100 tested positive for COVID-19. Among this subset of patients, a profound loss of smell and taste was quite common, but these senses usually came back within two to four weeks of infection, matching t...
Post a Comment
Read more

For The First Time, Scientists Find a Way to Make Targeted Edits to Mitochondrial DNA

Most cells in your body come with two genetic libraries; one in the nucleus, and the other inside structures called mitochondria - also known as the 'powerhouses of the cell'. Until now, we've only had a way to make changes to one. A combined effort by several research teams in the US has led to a process that could one day allow us to modify the instructions making up the cell's 'other' genome, and potentially treat a range of conditions that affect how we power our bodies. The molecular foundation of this revolutionary gene editing tool is a toxin called DddA, secreted by the bacterium Burkholderia cenocepacia to sabotage other microbes when competition over resources turns serious. Researchers from the University of Washington have had an interest in the toxin's talents for a while, finding it converts a nucleic acid base called cytosine into a different one commonly found in RNA, called uracil. It's far from the first time researchers have looked to ...
Post a Comment
Read more